DRUG DISCOVERY OUTSOURCING MARKET ANALYSIS

Drug Discovery Outsourcing Market, By Workflow (Target Identification & Screening, Target Validation & Functional Informatics, Lead Identification & Candidate Optimization, Preclinical Development, and Other Associated Workflow), By Therapeutic Area (Respiratory System, Pain and Anesthesia, Oncology, Ophthalmology, Hematology, Cardiovascular, Endocrine, Gastrointestinal, Immunomodulation, Anti-Infective, Central Nervous System, Dermatology, and Genitourinary System), By Drug Type (Small Molecule and Large Molecule), By Service Type (Chemistry Services and Biology Services), By End User (Pharmaceutical & Biotechnology Companies and Academic Institutes), By Region (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)

Published In : Jun 2023
Code : CMI2847
Pages :157
Formats :
Excel and PDF
Industry : Pharmaceutical

Market News

Global Drug Discovery Outsourcing Market: Key Developments

In January 2022, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. entered into a collaboration agreement with Insilico Medicine, an end-to-end artificial intelligence (AI)-driven drug discovery and development company to advance the discovery and development of drugs targeting a number of different targets globally through the use of AI technology.

In January 2022, Evotec partnered with Eli Lilly and Company for the drug discovery of metabolic diseases. Under the agreement, Evotec will identify potential drug candidates to treat diabetes and chronic kidney diseases from targets selected by either of the companies.

In September 2021, Eurofins and Liverpool ChiroChem Ltd. teamed up to offer improved chemical expertise by accessing Liverpool ChiroChem’s PROTAC linker molecules to augment the unified drug discovery platform, DiscoveryOne.

In July 2022, GenScript ProBio and DAAN Bio Therapeutics entered into a strategic cooperation regarding the development of innovative drug development and discovery.